BioCentury | May 5, 2014
Company News

Tenaxis, Medicines Co. deal

...front and up to $112 million in milestone payments. Tenaxis' sole marketed product is the Tenaxis...
...which uses a crosslinking agent to covalently bind human tissue and artificial grafts. Last year, Tenaxis...
...advisor. Tenaxis declined to disclose additional details, and The Medicines Co. could not be reached. Tenaxis Medical Inc....
Items per page:
1 - 1 of 1
BioCentury | May 5, 2014
Company News

Tenaxis, Medicines Co. deal

...front and up to $112 million in milestone payments. Tenaxis' sole marketed product is the Tenaxis...
...which uses a crosslinking agent to covalently bind human tissue and artificial grafts. Last year, Tenaxis...
...advisor. Tenaxis declined to disclose additional details, and The Medicines Co. could not be reached. Tenaxis Medical Inc....
Items per page:
1 - 1 of 1